Primary |
Epilepsy |
20.5% |
Convulsion |
15.4% |
Trigeminal Neuralgia |
8.5% |
Product Used For Unknown Indication |
6.8% |
Bipolar Disorder |
6.0% |
Pain |
6.0% |
Blood Pressure |
3.4% |
Depression |
3.4% |
Diabetes Mellitus |
3.4% |
Nervous System Disorder |
3.4% |
Off Label Use |
3.4% |
Petit Mal Epilepsy |
3.4% |
Blood Cholesterol Increased |
2.6% |
Hypertension |
2.6% |
Thyroid Disorder |
2.6% |
Asthma |
1.7% |
Blood Pressure Fluctuation |
1.7% |
Brain Oedema |
1.7% |
Cardiac Disorder |
1.7% |
Dyskinesia |
1.7% |
|
Convulsion |
9.8% |
Drug Dependence |
9.8% |
Tremor |
9.8% |
Epilepsy |
7.3% |
Death |
4.9% |
Memory Impairment |
4.9% |
No Adverse Event |
4.9% |
Skin Exfoliation |
4.9% |
Somnolence |
4.9% |
Stevens-johnson Syndrome |
4.9% |
Syncope |
4.9% |
Trigeminal Neuralgia |
4.9% |
Weight Decreased |
4.9% |
Wrong Technique In Drug Usage Process |
4.9% |
Arthropathy |
2.4% |
Brain Neoplasm |
2.4% |
Cerebrovascular Accident |
2.4% |
Chest Pain |
2.4% |
Diarrhoea |
2.4% |
Drug Ineffective |
2.4% |
|
Secondary |
Epilepsy |
19.0% |
Convulsion |
17.7% |
Product Used For Unknown Indication |
10.2% |
Trigeminal Neuralgia |
10.2% |
Petit Mal Epilepsy |
8.2% |
Blood Pressure Fluctuation |
4.1% |
Depression |
3.4% |
Angina Pectoris |
2.7% |
Blood Cholesterol Increased |
2.7% |
Facial Pain |
2.7% |
Myalgia |
2.7% |
Nerve Injury |
2.7% |
Off Label Use |
2.7% |
Blood Cholesterol |
2.0% |
Pain |
2.0% |
Bipolar Disorder |
1.4% |
Cardiac Disorder |
1.4% |
Diabetes Mellitus |
1.4% |
Dyskinesia |
1.4% |
Hypertension |
1.4% |
|
Trigeminal Neuralgia |
12.8% |
Hyponatraemia |
8.5% |
Rash |
8.5% |
Somnolence |
8.5% |
Sleep Disorder |
6.4% |
Suicide Attempt |
6.4% |
Syncope |
6.4% |
Convulsion |
4.3% |
No Adverse Event |
4.3% |
Underdose |
4.3% |
Vaginal Discharge |
4.3% |
Vomiting |
4.3% |
White Blood Cell Count Decreased |
4.3% |
Wrong Technique In Drug Usage Process |
4.3% |
Feeling Abnormal |
2.1% |
Feeling Cold |
2.1% |
Incorrect Dose Administered |
2.1% |
Memory Impairment |
2.1% |
Petit Mal Epilepsy |
2.1% |
Pyrexia |
2.1% |
|
Concomitant |
Product Used For Unknown Indication |
33.8% |
Convulsion |
10.8% |
Osteoporosis |
8.1% |
Bipolar Disorder |
6.8% |
Cardiovascular Event Prophylaxis |
5.4% |
Epilepsy |
4.1% |
Prophylaxis |
4.1% |
Attention Deficit/hyperactivity Disorder |
2.7% |
Cardiac Disorder |
2.7% |
Chronic Obstructive Pulmonary Disease |
2.7% |
Hormone Level Abnormal |
2.7% |
Hypertension |
2.7% |
Multiple Sclerosis |
2.7% |
Pain |
2.7% |
Anxiety |
1.4% |
Depression |
1.4% |
Diabetes Mellitus |
1.4% |
Gastrooesophageal Reflux Disease |
1.4% |
Hypercholesterolaemia |
1.4% |
Hyperlipidaemia |
1.4% |
|
Blood Sodium Decreased |
18.2% |
Anaemia |
9.1% |
Bipolar Disorder |
9.1% |
Convulsion |
9.1% |
Psychotic Disorder |
9.1% |
Rash Pruritic |
9.1% |
Red Blood Cell Count Increased |
9.1% |
Skin Necrosis |
9.1% |
Vomiting |
9.1% |
Weight Decreased |
9.1% |
|